Variant report
Variant | esv2763890 |
---|---|
Chromosome Location | chr5:27521149-27544770 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:27530537..27533471-chr5:27821180..27823240,2 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C5orf17-14 | chr5:27520790-27521692 | ucscGeneNc_uc003jgv_1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs138980266 | chr5:27521168-27521169 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs187926291 | chr5:27521187-27521188 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs546323639 | chr5:27521209-27521210 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs561302980 | chr5:27521248-27521249 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs528968600 | chr5:27521263-27521264 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs191542552 | chr5:27521273-27521274 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs182571086 | chr5:27521301-27521302 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs539285090 | chr5:27521332-27521333 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs551539984 | chr5:27521354-27521355 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs141263637 | chr5:27521371-27521372 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs566693958 | chr5:27521381-27521382 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs188038610 | chr5:27521406-27521407 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs141339408 | chr5:27521425-27521426 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs574850692 | chr5:27521446-27521447 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs150780712 | chr5:27521480-27521481 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs139137161 | chr5:27521484-27521485 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs555868838 | chr5:27521485-27521486 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs111513908 | chr5:27521488-27521489 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs77747459 | chr5:27521566-27521567 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs149383713 | chr5:27521571-27521572 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs113910567 | chr5:27521588-27521589 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs141558932 | chr5:27521600-27521601 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs202213278 | chr5:27521602-27521603 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs138328219 | chr5:27521615-27521616 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs564696472 | chr5:27521632-27521633 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs112095705 | chr5:27521649-27521650 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs2329623 | chr5:27521650-27521651 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs184915369 | chr5:27521663-27521664 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs528832005 | chr5:27521680-27521681 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs538351460 | chr5:27523600-27523601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142448631 | chr5:27523732-27523733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs370445326 | chr5:27523733-27523734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs372992514 | chr5:27523779-27523780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs561084474 | chr5:27523789-27523790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs113048169 | chr5:27523796-27523797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576278157 | chr5:27523837-27523838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs151307499 | chr5:27523839-27523840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140535546 | chr5:27523860-27523861 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs75115148 | chr5:27523867-27523868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs551799371 | chr5:27523868-27523869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs187431395 | chr5:27523877-27523878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs527791248 | chr5:27523922-27523923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549036461 | chr5:27523928-27523929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs531456904 | chr5:27523963-27523964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374919812 | chr5:27523973-27523974 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538466327 | chr5:27523974-27523975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549562427 | chr5:27530216-27530217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs73073612 | chr5:27530237-27530238 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs532051518 | chr5:27530238-27530239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs550232906 | chr5:27530252-27530253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:27523600-27524000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr5:27523800-27524000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr5:27530200-27531800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
4 | chr5:27531600-27532400 | Enhancers | H9 Cell Line | embryonic stem cell |
5 | chr5:27531800-27532400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr5:27531800-27532400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr5:27531800-27532400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr5:27532400-27533400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
9 | chr5:27532400-27533600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
10 | chr5:27533200-27533600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr5:27533400-27533600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
12 | chr5:27533800-27534000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
13 | chr5:27543800-27544000 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr5:27544000-27551600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |